Trulieve CTO receives RSU and option grants

Trulieve Cannabis Corp. Chief Technology Officer Nilyum Jhala reported equity compensation awards.

Rhea-AI Filing Summary

Trulieve Cannabis Corp. Chief Technology Officer Nilyum Jhala reported equity compensation awards. Jhala received 58,594 restricted stock units, each representing one subordinate voting share, with 50% vesting on December 1, 2027 and 50% on December 1, 2028.

Jhala was also granted a stock option for 41,668 subordinate voting shares at an exercise price of 6.40 per share, vesting in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028, and expiring on March 13, 2033. Following these awards, Jhala directly owns 239,254 subordinate voting shares and has indirect beneficial ownership of 7,000 shares held by a spouse.

Insider Trade Summary

Grant/Award: 100,262 shares

Grant/Award 3 txns

Insider Jhala Nilyum

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	41,668	$0.00	$0.00
Grant/Award	Subordinate Voting Shares	58,594	$0.00	$0.00
holding	Subordinate Voting Shares	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 41,668 contracts (Direct); Subordinate Voting Shares — 239,254 shares (Direct); Subordinate Voting Shares — 7,000 shares (Indirect, By Spouse)

Footnotes (2)

1. F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.
2. F2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Trulieve (TCNNF) grant to its CTO in this Form 4?

Trulieve granted Chief Technology Officer Nilyum Jhala 58,594 restricted stock units and a stock option for 41,668 subordinate voting shares. These awards are compensation-related grants, not open-market purchases or sales, and vest over several years according to specified schedules.

How do the new restricted stock units for Trulieve (TCNNF) CTO vest?

The 58,594 restricted stock units granted to CTO Nilyum Jhala vest in two tranches. Half of the units vest on December 1, 2027, and the remaining half vest on December 1, 2028, tying long-term compensation to continued service at Trulieve.

What are the key terms of the Trulieve (TCNNF) CTO stock option grant?

The stock option covers 41,668 subordinate voting shares at an exercise price of 6.40 per share. It vests in three equal annual installments on December 1 of 2026, 2027, and 2028, and is scheduled to expire on March 13, 2033, if not exercised.

How many Trulieve (TCNNF) shares does the CTO hold after these transactions?

After the reported awards, CTO Nilyum Jhala directly owns 239,254 subordinate voting shares. In addition, there is indirect beneficial ownership of 7,000 subordinate voting shares held by a spouse, reflecting both direct and family-related holdings reported in the filing.

Are the Trulieve (TCNNF) CTO transactions open-market buys or routine compensation?

The transactions are routine compensation grants, not market trades. The Form 4 identifies them with code A as grants or awards, covering restricted stock units and stock options awarded at no purchase price, with vesting over future dates and no immediate cash transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jhala Nilyum

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	03/13/2026		A		58,594(1)	A	$0	239,254	D
Subordinate Voting Shares								7,000	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.4	03/13/2026		A		41,668		(2)	03/13/2033	Subordinate Voting Shares	41,668	$0	41,668	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.

2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.